Skip to main content

Advertisement

Log in

Early Timing of Thyroidectomy for Hyperthyroidism in Graves’ Disease Improves Biochemical Recovery

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The role of thyroidectomy as an early treatment for hyperthyroidism has been poorly investigated. Our aim was to examine its success rates, particularly focusing on thyroidectomy as an early treatment.

Methods

Patients with thyroidectomy for hyperthyroidism between February 2008 and October 2014 were included. They were divided into two groups (early and delayed thyroidectomy), and patient characteristics, treatment indications, complications and time to biochemical recovery were analyzed.

Results

Ninety-nine patients met the inclusion criteria, of whom 65 (66%) suffered from Graves’ disease, 25 (25%) from toxic goiters and 9 (9%) from amiodarone-induced hyperthyroidism. Structural abnormalities of the thyroid (39 patients, 39%) represented the most frequent indications for thyroidectomy. Forty-six patients (46%) underwent an early and 53 (54%) a delayed surgical approach. Patients with Graves’ disease undergoing early thyroidectomy did not suffer more often from complications but had a significantly faster biochemical recovery after surgery than those with a delayed thyroidectomy, as judged by a shorter time to reach TSH (121 ± 24 vs. 240 ± 31 days, p = 0.007) and fT4 (91 ± 29 vs. 183 ± 31 days p = 0.015) levels in the normal range. As expected, there were no recurrences of hyperthyroidism.

Conclusions

Early thyroidectomy was neither associated with permanent complications nor thyroid storm, but with a significantly improved biochemical recovery and therefore has to be recommended early in patients with Graves’ disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Yip J, Lang BH, Lo CY (2012) Changing trend in surgical indication and management for Graves’ disease. Am J Surg 203:162–167

    Article  PubMed  Google Scholar 

  2. Ríos A, Rodríguez JM, Balsalobre MD et al (2005) Results of surgery for toxic multinodular goiter. Surg Today 35:901–906

    Article  PubMed  Google Scholar 

  3. Bahn RS, Burch HB, Cooper DS et al (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17:456–520

    Article  PubMed  Google Scholar 

  4. Cooper DS (2003) Antithyroid drugs in the management of patients with Graves’ disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab 88:3474–3481

    Article  CAS  PubMed  Google Scholar 

  5. Yaqub A, Choudhry MI, Wheaton J et al (2011) Post-ablative hypothyroidism. W Va Med J 107:37–40

    Google Scholar 

  6. Metso S, Jaatinen P, Huhtala H et al (2004) Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol (Oxf) 61:641–648

    Article  CAS  Google Scholar 

  7. Reid DJ (1987) Hyperthyroidism and hypothyroidism complicating the treatment of thyrotoxicosis. Br J Surg 74:1060–1062

    Article  CAS  PubMed  Google Scholar 

  8. Hyer SL, Newbold K, Harmer CL (2010) Early and late toxicity of radioiodine therapy: detection and management. Endocr Pract 16:1064–1070

    Article  PubMed  Google Scholar 

  9. Bakos B, Takács I, Nagy Z et al (2013) Long term efficacy of radioiodine treatment in hyperthyroidism. Exp Clin Endocrinol Diabetes 121:494–497

    Article  CAS  PubMed  Google Scholar 

  10. Szumowski P, Rogowski F, Abdelrazek S et al (2012) Iodine isotope 131I therapy for toxic nodular goitre: treatment efficacy parameters. Nucl Med Rev Cent East Eur 15:7–13

    Article  PubMed  Google Scholar 

  11. Bonnema SJ, Hegedüs L (2012) Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev 33:920–980

    Article  CAS  PubMed  Google Scholar 

  12. Bhatia KS, Lee YY, Yuen EH et al (2013) Ultrasound elastography in the head and neck. Part I. Basic principles and practical aspects. Cancer Imaging 13:253–259

    Article  PubMed  PubMed Central  Google Scholar 

  13. Genovese BM, Noureldine SI, Gleeson EM et al (2013) What is the best definitive treatment for Graves’ disease? A systematic review of the existing literature. Ann Surg Oncol 20:660–667

    Article  PubMed  Google Scholar 

  14. Annerbo M, Stålberg P, Hellman P (2012) Management of Grave’s disease is improved by total thyroidectomy. World J Surg 36:1943–1946. doi:10.1007/s00268-012-1617-x

    Article  PubMed  Google Scholar 

  15. Witte J, Goretzki PE, Dotzenrath C et al (2000) Surgery for Graves’ disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg 24:1303–1311. doi:10.1186/1745-6215-13-234

    Article  CAS  PubMed  Google Scholar 

  16. Brent GA (2008) Clinical practice. Graves’ disease. N Engl J Med 358:2594–2605

    Article  CAS  PubMed  Google Scholar 

  17. Bartalena L, Brogioni S, Grasso L et al (1996) Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 81:2930–2933

    CAS  PubMed  Google Scholar 

  18. Bogazzi F, Bartalena L, Martino E (2010) Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95:2529–2535

    Article  CAS  PubMed  Google Scholar 

  19. Franzese CB, Stack BC (2002) Amiodarone-induced thyrotoxicosis: a case for surgical management. Am J Otolaryngol 23:358–361

    Article  PubMed  Google Scholar 

  20. Gough J, Gough IR (2006) Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg 30:1957–1961. doi:10.1007/s00268-005-0673-x

    Article  PubMed  Google Scholar 

  21. Meerwein C, Vital D, Greutmann M et al (2014) Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery? HNO 62:100–105

    Article  CAS  PubMed  Google Scholar 

  22. Phitayakorn R, Morales-Garcia D, Wanderer J et al (2013) Surgery for Graves’ disease: a 25-year perspective. Am J Surg 206:669–673

    Article  PubMed  Google Scholar 

  23. Sundaresh V, Brito JP, Wang Z et al (2013) Comparative effectiveness of therapies for Graves’ hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab 98:3671–3677

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Palit TK, Miller CC, Miltenburg DM (2000) The efficacy of thyroidectomy for Graves’ disease: a meta-analysis. J Surg Res 90:161–165

    Article  CAS  PubMed  Google Scholar 

  25. Barczyński M, Konturek A, Hubalewska-Dydejczyk A et al (2012) Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves’ disease with a 5-year follow-up. Br J Surg 99:515–522

    Article  PubMed  Google Scholar 

  26. Vasica G, O’Neill CJ, Sidhu SB et al (2012) Reoperative surgery for bilateral multinodular goitre in the era of total thyroidectomy. Br J Surg 99:688–692

    Article  CAS  PubMed  Google Scholar 

  27. Grodski S, Stalberg P, Robinson BG et al (2007) Surgery versus radioiodine therapy as definitive management for graves’ disease: the role of patient preference. Thyroid 17:157–160

    Article  PubMed  Google Scholar 

  28. Scerrino G, Morfino G, Paladino NC et al (2013) Does thyroid surgery for Graves’ disease improve health-related quality of life? Surg Today 43:1398–1405

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerhard F. Huber.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vital, D., Morand, G.B., Meerwein, C. et al. Early Timing of Thyroidectomy for Hyperthyroidism in Graves’ Disease Improves Biochemical Recovery. World J Surg 41, 2545–2550 (2017). https://doi.org/10.1007/s00268-017-4052-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-017-4052-1

Navigation